The present invention is directed to imidazolyl derivatives of formula (I) where the substituents are defined in the specification, which are useful as agonists or antagonists of somatostatin receptors.
申请人:Societe de Conseils de Recherches etd' Application Scientifiques, S.A.S. a Paris, France corp.
公开号:US20040038970A1
公开(公告)日:2004-02-26
The present invention is directed to compounds of formula (I) wherein the variables are defined in the specification, which bind to somatostatin receptors and block Na channels.